Advancement of nanomedicines in chronic inflammatory disorders

V Jogpal, M Sanduja, R Dutt, V Garg, Tinku - Inflammopharmacology, 2022 - Springer
Chronic diseases, as stated by the WHO, are a threat to human health which kill 3 out of
every 5 people worldwide. Therapeutics for such illnesses can be developed using …

A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis

KR Chaudhary, V Puri, A Singh, C Singh - Journal of Drug Delivery Science …, 2022 - Elsevier
Tuberculosis (TB) has been the most life-threatening contagious disease caused by
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …

Right or left: the role of nanoparticles in pulmonary diseases

X Lu, T Zhu, C Chen, Y Liu - International journal of molecular sciences, 2014 - mdpi.com
Due to the rapid development of the nanotechnology industry in the last decade,
nanoparticles (NPs) are omnipresent in our everyday life today. Many nanomaterials have …

Macrophage-targeted nanomedicines for ARDS/ALI: Promise and potential

R Vichare, JM Janjic - Inflammation, 2022 - Springer
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by
progressive lung impairment typically triggered by inflammatory processes. The mortality toll …

Nanomedicine for respiratory diseases

U Pison, T Welte, M Giersig, DA Groneberg - European journal of …, 2006 - Elsevier
Nanotechnology provides new materials in the nanometer range with many potential
applications in clinical medicine and research. Due to their unique size-dependent …

Nanotechnology in respiratory medicine

AJ Omlor, J Nguyen, R Bals, QT Dinh - Respiratory Research, 2015 - Springer
Like two sides of the same coin, nanotechnology can be both boon and bane for respiratory
medicine. Nanomaterials open new ways in diagnostics and treatment of lung diseases …

[引用][C] Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review

G Sheng, N Tian, H Duan, Z Sun, H Chu - Acta Materia Medica, 2022 - Compuscript

The nanosystems involved in treating lung cancer

A Crintea, AG Dutu, G Samasca, IA Florian, I Lupan… - Life, 2021 - mdpi.com
Even though there are various types of cancer, this pathology as a whole is considered the
principal cause of death worldwide. Lung cancer is known as a heterogeneous condition …

Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders

M Kumar, A Jha, K Bharti, G Parmar, B Mishra - Nanomedicine, 2022 - Taylor & Francis
Inflammatory lung disorders have become one of the fastest growing global healthcare
concerns, with more than 500 million annual cases of disorders such as chronic obstructive …

Nanotechnology solutions for mucosal immunization

S Chadwick, C Kriegel, M Amiji - Advanced drug delivery reviews, 2010 - Elsevier
The current prevalence of infectious diseases in many developing regions of the world is a
serious burden, impacting both the general health as well as economic growth of these …